Reaction

Application Site Perspiration reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 173 reports · 3 co-occurring drugs

As of the last recalculation, Application Site Perspiration appears in 173 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is NICOTINE (PRR 107.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Nicotine30107.7107.8
Buprenorphine4578.778.8
Minoxidil719.519.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.